NASDAQ · IRMD
iRadimed Corporation
U.S. listed stock · USD15-minute delay
Find an instrument
- AppleAAPL · NASDAQResearch →
- MicrosoftMSFT · NASDAQResearch →
- NvidiaNVDA · NASDAQResearch →
- AmazonAMZN · NASDAQResearch →
- AlphabetGOOGL · NASDAQResearch →
- Meta PlatformsMETA · NASDAQResearch →
- TeslaTSLA · NASDAQResearch →
- JPMorgan ChaseJPM · NYSEResearch →
- ExxonMobilXOM · NYSEResearch →
- WalmartWMT · NASDAQResearch →
- S&P 500 IndexSPX · S&PResearch →
- Nasdaq 100 IndexNDX · NASDAQResearch →
- Dow Jones Industrial AverageDJI · Dow JonesResearch →
- Cboe Volatility IndexVIX · CboeResearch →
- U.S. Dollar IndexDXY · ICEResearch →
- VIX futuresVX1! · Cboe Futures ExchangeResearch →
- DAX futuresFDAX1! · EurexResearch →
- Euro Stoxx 50 futuresFESX1! · EurexResearch →
- E-mini S&P 500 futuresES1! · CMEResearch →
- E-mini Nasdaq 100 futuresNQ1! · CMEResearch →
- E-mini Dow futuresYM1! · CBOTResearch →
- E-mini Russell 2000 futuresRTY1! · CMEResearch →
- WTI crude oil futuresCL1! · NYMEXResearch →
- Natural gas futuresNG1! · NYMEXResearch →
- Gold futuresGC1! · COMEXResearch →
- Silver futuresSI1! · COMEXResearch →
- Euro FX futures6E1! · CMEResearch →
- Japanese yen futures6J1! · CMEResearch →
- BitcoinBTCUSD · BitstampResearch →
- EtherETHUSD · BitstampResearch →
- Research Any U.S. stock or ETF tickerResearch →
No matching names. Type a U.S. stock ticker (for example MU) to research it.
Loading price chart…
15-minute delay. Chart times and available timeframes are controlled by the provider.
Earnings
Earnings calendarThe next earnings date for IRMD has not been announced yet.
| Fiscal quarter end | Consensus EPS forecast | High | Low | Estimates |
|---|---|---|---|---|
| Sep 2026 | $0.52 | $0.54 | $0.49 | 1 |
Source: Nasdaq, based on Zacks Investment Research consensus estimates. Dates marked as expected may change.
News
RTTNews · BNK Invest · The Motley Fool · MarketBeat- RTTNews · Oct 30, 11:52 AM EDTIradimed Q3 Profit Climbs 17% On Higher Sales; Trims Upper End Of FY26 Outlook(RTTNews) – Iradimed Corp. (IRMD) reported Friday higher third-quarter earnings and revenue while narrowing its full-year financial forecasts.
- BNK Invest · Sep 4, 4:02 PM EDTiRadimed Becomes OversoldThe DividendRank formula at Dividend Channel ranks a coverage universe of thousands of dividend stocks, according to a proprietary formula designed to identify those stocks that combine two important characteristics — strong fundamentals and a valuation that looks inexpensive.
- The Motley Fool · Aug 7, 10:44 PM EDTIRadimed (IRMD) Q2 2026 Earnings Call Transcript@media (max-width: 768px) { .image-container { width: 100% !important; float: none !important; margin: 0 0 1rem 0 !important; } } Image source: The Mo
- MarketBeat · Jul 31, 1:04 PM EDTiRadimed Q2 Earnings Call HighlightsiRadimed (NASDAQ:IRMD) reported second-quarter 2026 revenue of $20.5 million, up 0.5% from a year earlier, as the company began general-release production of its new 3870 MRI IV pump system and worked through the costs associated with an initial manufacturing ramp. GAAP net inco
- RTTNews · Jul 31, 8:26 AM EDTIradimed Corporation Profit Drops In Q2(RTTNews) – Iradimed Corporation (IRMD) revealed earnings for second quarter that Drops, from the same period last year
- RTTNews · Jul 27, 6:20 AM EDTCan IradiMed Extend Its Earnings Momentum In Q2 2026, Will Device Sales Continue To Climb?(RTTNews) – IRADIMED CORPORATION (IRMD), a medical device company, announced Friday that it will release its results for the second quarter of fiscal 2026 before the market opens on July 31, 2026. The company's management will host a conference call at 11:00 a.m. ET to discuss th
- The Motley Fool · Jun 2, 8:29 AM EDTIRADIMED's CEO Is Selling Steadily — The Plan, Not the Stock, Is Driving ItCEO Roger E. Susi sold 7,500 shares indirectly for a transaction value of approximately $691,000.
- The Motley Fool · May 25, 9:02 PM EDTIradimed’s CEO and Founder Sold 7,500 Company Shares. What Does That Mean for Investors?CEO and company founder Roger Susi sold 7,500 indirectly-held shares for a total transaction value of ~$657,000 at a weighted average price of around $87.64 per share on May 18 and May 19, 2026.
- Zacks · May 4, 9:33 AM EDTCompany News for May 4, 2026Companies in The News Are: NWL,CL,EL,IRMD
- RTTNews · May 4, 4:34 AM EDTIRADIMED Q1 Revenue Improves; Guides For Q2 And Reaffirms FY26 Guidance(RTTNews) – IRADIMED CORPORATION (IRMD), an Magnetic Resonance Imaging or MRI compatible medical device manufacturer, announced financial results for the three months ended March 31, 2026, reflecting 13% revenue growth. In addition, the firm provided second-quarter guidance and r
- The Motley Fool · May 1, 8:08 PM EDTWhy Iradimed Stock Topped the Market TodayCompounding that, it topped analyst estimates on both the top and bottom lines.
- Zacks · May 1, 9:45 AM EDTiRadimed (IRMD) Beats Q1 Earnings and Revenue EstimatesiRadimed (IRMD) delivered earnings and revenue surprises of +8.89% and +1.61%, respectively, for the quarter ended March 2026. Do the numbers hold clues to what lies ahead for the stock?
Stories from Nasdaq.com, including Zacks, The Motley Fool and Barchart. They open on the publisher’s site; AiFs Market does not edit or endorse them.
Company profile
Loading company profile…
Financials
Loading fundamental data…
More headlines
More stories for iRadimed Corporation from TradingView. Coverage varies.
Loading related news…
Quotes, charts, company information and headlines are supplied by TradingView. Data may be delayed or unavailable. This page is for market research and does not provide investment advice.